AMCP supports the implementation and expanded use of health information technology (HIT), including electronic health records and electronic prescribing.
Government & Advocacy
AMCP advocates on behalf of managed care pharmacy professionals to ensure that their interests and the patients they serve are considered in federal and state health care policy decisions.
Featured Legislative & Regulatory Positions
See all Positions
The Academy of Managed Care Pharmacy (AMCP) supports an abbreviated licensure pathway for the approval of biosimilar biologic drug therapies.
AMCP opposes government regulation of drug pricing because of the potential for unintended consequences and supports the elimination of barriers to competition to bring down the high cost of prescription drugs.
Featured Resources
See More Resources
Regulatory Updates
Letters, Statements, and Analysis
See All Letters, Statements, & Analysis
H.R. 1, or the Big Beautiful Bill, has brought substantial change to the managed care pharmacy landscape, particularly for managed care organizations (MCOs) with managed Medicaid lines of business.
HealthyWomen, members of its HPV Coalition and additional stakeholders are writing the Advisory Committee on Immunization Practices (ACIP) regarding the upcoming June ACIP meeting June 25-27, 2025, docket number - CDC-2005-0024.
Today, Senator Josh Hawley (R-MO) introduced legislation that would rollback some of the impending cuts to federal Medicaid funding as mandated by H.R. 1.
Latest NewsBREAKS & Briefings
Explore Advocacy Resources
Take Action
Grassroots Advocacy
AMCP represents managed care pharmacy in meetings with federal lawmakers and regulators and submits comments on proposed rules and regulations. We need and urge your participation in this process through our grassroots advocacy program.
